Most people taking Saxenda lose about 8% of their body weight over the course of a year. In the largest clinical trial, that translated to roughly 18.5 pounds on average, compared to about 6 pounds for people making the same diet and exercise changes without the medication. Your individual results will depend on your starting weight, how your body responds, and whether you pair the medication with consistent lifestyle changes.
Average Weight Loss After One Year
The primary study behind Saxenda’s approval, known as the SCALE Obesity and Prediabetes trial, followed participants for 56 weeks. Those taking the full dose lost an average of 8% of their body weight (about 8.4 kilograms, or 18.5 pounds), while people on placebo lost just 2.6% (about 6.2 pounds). That means roughly 5.4 percentage points of weight loss can be attributed directly to the medication itself, above and beyond the effects of diet and exercise alone.
To put that in practical terms: a person starting at 250 pounds could expect to lose around 20 pounds over a year on Saxenda. Someone starting at 200 pounds might lose closer to 16 pounds. These are averages, and the range is wide. Some people lose significantly more, while others see minimal change.
The 16-Week Checkpoint
Not everyone responds to Saxenda equally, and there’s a reliable way to tell early on whether the medication is working for you. If you’ve lost at least 4% of your body weight by 16 weeks, you’re on track for meaningful results. This threshold correctly predicts one-year success about 80% of the time.
People who hit that 4% mark (called “early responders”) went on to lose an average of 10.8% of their body weight by the end of the year. Those who didn’t reach 4% at 16 weeks averaged only about 3% total weight loss. The difference is dramatic enough that the FDA label includes a stopping rule: if you haven’t lost at least 4% of your body weight after 16 weeks on the full dose, the medication likely isn’t going to deliver significant results for you, and discontinuing it is a reasonable conversation to have with your prescriber.
How Saxenda Causes Weight Loss
Saxenda works through several overlapping mechanisms that all point in the same direction: you feel less hungry and eat less food. The active ingredient mimics a hormone called GLP-1 that your gut naturally releases after eating. When you take Saxenda, it activates GLP-1 receptors in multiple areas of the brain that regulate appetite, directly reducing the drive to eat.
It also slows how quickly food leaves your stomach. In clinical testing, people on Saxenda took measurably longer to empty half their stomach contents compared to those on placebo. This means food sits in your stomach longer, and you feel full sooner. Participants reached comfortable fullness on a significantly smaller volume of food and consumed fewer calories during meals when they could eat as much as they wanted. The combined effect of reduced appetite signals in the brain and slower digestion makes it physically easier to eat less without feeling deprived.
The Dose Escalation Period
Saxenda is a daily injection that you administer yourself, typically in the abdomen, thigh, or upper arm. You don’t start on the full dose. Instead, the medication is gradually increased over five weeks to minimize nausea and other digestive side effects:
- Week 1: 0.6 mg daily
- Week 2: 1.2 mg daily
- Week 3: 1.8 mg daily
- Week 4: 2.4 mg daily
- Week 5 onward: 3.0 mg daily (maintenance dose)
Most of the weight loss in clinical trials occurred once participants reached the full 3.0 mg dose and stayed on it. The titration period is essentially a ramp-up phase where your body adjusts to the medication.
Results in Adolescents
Saxenda is approved for patients aged 12 and older who have a body weight above 60 kg (about 132 pounds) and meet obesity criteria. In a 56-week trial of 251 adolescents, those taking Saxenda lost an average of 2.65% of their body weight, while those on placebo actually gained an average of 2.37%. That net difference of about 5 percentage points is similar to what’s seen in adults, though the absolute weight loss numbers tend to be smaller because adolescents are still growing and BMI is interpreted differently in this age group.
Who Tends to Lose More
A few patterns emerge from the clinical data. Women and people with lower body weight at a given BMI tend to achieve higher blood levels of the drug, which may translate to greater weight loss. People with high cholesterol or other lipid abnormalities also appear to lose more weight on liraglutide. One study found that those with dyslipidemia were about 1.7 times more likely to lose weight compared to those without it.
The strongest predictor, though, is simply whether the drug works for you in the first four months. That early response at 16 weeks is more informative than any demographic factor.
What Happens When You Stop
Weight regain after stopping Saxenda is common and worth planning for. The medication works by suppressing appetite and slowing digestion, so when those effects disappear, your hunger signals return to their previous baseline. One study found that people who took Saxenda without an exercise program regained an average of 6 kilograms (about 13 pounds) more than those who had combined the medication with regular physical activity during treatment.
Exercise during treatment appears to be protective. People who built a consistent exercise habit while taking Saxenda were 4.2 times more likely to maintain at least a 10% weight loss one year after stopping the drug, compared to those who relied on the medication alone. This suggests that Saxenda works best when treated as a window of opportunity to build sustainable habits, not as a standalone solution. The appetite suppression makes it easier to eat less and move more, and the habits you establish during that period are what carry you forward once you stop.
Continuing the medication long-term is also an option. Saxenda is approved for ongoing use to maintain weight reduction, and many people stay on it indefinitely precisely because weight tends to return after discontinuation.